ArticleOncology research2017

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer.

Kazuyoshi Kawakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.